Flibanserin like Viagra for men increases sex drive.

Drugmaker Pfizer’s hopes that its “little blue pill” would also ignite female libido fizzled, however, making it clear that a woman’s sexuality is more complicated than a man’s. Germany’s Boehringer Ingelheim is optimistic that flibanserin is on the verge of becoming the first prescription medication to tap what some have estimated could be a $2 billion market in the United States alone.

The request of bringing into market, Viagra for females, by a prominent German Pharmaceutical Company, will be evaluated and discussed by the Food and Drug Administration committee next month.

FDA will be considering the drug that claims to boost the sex lives of women. The Company has named the drug “flibanserin” and it has been said that the drug helps to arouse woman’s sexual desire as it deceives the chemicals in the brain cells.

It is known that the drug initially was developed as an anti-depressant, but it was then found that it can improve sexual desire in women by about 18%.

The FDA’s Reproductive Health Drugs Advisory Committee is scheduled to decide upon considering the drug on June 18.

Before anything could be approved, the drug has become a topic of discussion for pharmacies and also the medical people. On one hand where the Company is of a view that the drug is for offering options for females, some are worried that this is a potentially dangerous drugs and can cause problems if it is introduced.

The head of Company’s Clinical Research for the drug particularly, this drug will provide women with a safe and effective option.

According to Amy Allina of the National Women’s Health Network, however healthy and happy sex life is as important for women as it is for men, but the new drug before implementation needs to answer a number of questions.